Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein
Shiqi Xu(Institut Pasteur of Shanghai), Zhong Huang(Shenzhen University), Yanxing Wang(Chinese Academy of Sciences), Zuyang Li(Center for Excellence in Molecular Cell Science), Bingjie Zhou, Dimitri Lavillette(Soochow University), Qixing Liu(Chinese Academy of Sciences), Tingfeng Wang(Pudong Medical Center), Yuanfei Zhu(Shanghai Medical College of Fudan University), Jinkai Zang(The Ohio State University), Yong Yang(Chinese Academy of Sciences), Yifan Wang(Chinese Academy of Sciences), Chao Zhang(Fudan University), Youhua Xie(Shanghai Medical College of Fudan University), Yao Cong(Center for Excellence in Molecular Cell Science), Chenjian Gu(Washington University in St. Louis), Haikun Wang(Peking University), Rong Xu(Institut Pasteur of Shanghai), Hong Qin(Shanghai Clinical Research Center), Lulu Bai(National Institute for Communicable Disease Control and Prevention), Yu Zhou(Yangtze University), Gary Wong(Ministry of Health), Qiang Deng(Kunming University of Science and Technology)
Cited by 31
Related Papers
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
|Trends in Microbiology|2016|3.1k
Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections
|medRxiv|2020|692
Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids
|Protein & Cell|2020|397
Rapid and ultrasensitive electromechanical detection of ions, biomolecules and SARS-CoV-2 RNA in unamplified samples
|Nature Biomedical Engineering|2022|332